Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
Br J Dermatol
.
2024 Nov 18;191(6):1012-1013.
doi: 10.1093/bjd/ljae289.
Authors
Angelo Li
1
,
Annelie H Musters
1
,
Ariënna Hyseni
1
,
Louise A A Gerbens
1
2
,
Phyllis I Spuls
1
2
Affiliations
1
Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
2
Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
PMID:
39005169
DOI:
10.1093/bjd/ljae289
No abstract available
Grants and funding
TREAT NL
ZONMW_/ZonMw/Netherlands
The Netherlands Organization for Health Research and Development, Rational Pharmacotherapy programme
Galderma
LEO Pharma
Novartis
Pfizer
Sanofi-Genzyme